Skip to content
Nikang Therapeutics
About Us
Science & Pipeline
News
Careers
Home
About us
Science & Pipeline
News
Careers
NiKang Therapeutics® to Present Preliminary Results of Phase 1/2 Clinical Trial of NKT2152 in Patients with Previously Treated Advanced Clear Cell Renal Cell Carcinoma at ESMO 2024 Congress
See the press release on
Business Wire